You can buy or sell SLDB and other stocks, options, and ETFs commission-free!
Solid Biosciences, Inc. engages in the development of treatments for patients with Duchenne muscular dystrophy. It develops gene therapies, disease modifying therapies, and assistive devices for the cure of DMD. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Arnold, Annie Ganot and Gilad David Hayeem in March 2013 and is headquartered in Cambridge, MA. The listed name for SLDB is Solid Biosciences Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Mar 11, Pre-Market